Franklin Resources
LGND icon

Franklin Resources’s Ligand Pharmaceuticals LGND Stock Holding History

Franklin Resources’s Portfolio LGND Stock Details LGND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$238M Buy
752,044
+178,867
+31% +$42.1M 0.05% 296
2026
Q1 		$114M Buy
573,177
+77,017
+16% +$15.2M 0.03% 400
2025
Q4 		$93.8M Buy
496,160
+266,304
+116% +$51.2M 0.02% 447
2025
Q3 		$40.7M Buy
229,856
+43,757
+24% +$6.51M 0.01% 708
2025
Q2 		$21.2M Sell
186,099
-258
-0.1% -$27.6K 0.01% 908
2025
Q1 		$19.6M Buy
186,357
+955
+0.5% +$108K 0.01% 905
2024
Q4 		$19.9M Buy
185,402
+90,743
+96% +$10.3M 0.01% 916
2024
Q3 		$9.79M Buy
94,659
+78,973
+503% +$7.95M ﹤0.01% 1133
2024
Q2 		$1.32M Buy
15,686
+1,747
+13% +$139K ﹤0.01% 1825
2024
Q1 		$1.02M Sell
13,939
-127
-0.9% -$9.36K ﹤0.01% 1945
2023
Q4 		$1M Buy
14,066
+438
+3% +$25.8K ﹤0.01% 1641
2023
Q3 		$817K Buy
13,628
+4,191
+44% +$276K ﹤0.01% 1689
2023
Q2 		$680K Buy
+9,437
New +$708K ﹤0.01% 1816
2022
Q3 		– Sell
-3,647
Closed -$203K – 2359
2022
Q2 		$203K Sell
3,647
-476
-12% -$27K ﹤0.01% 2018
2022
Q1 		$290K Buy
4,123
+50
+1% +$3.63K ﹤0.01% 2026
2021
Q4 		$392K Buy
4,073
+308
+8% +$28.5K ﹤0.01% 1996
2021
Q3 		$328K Buy
3,765
+1,268
+51% +$98.1K ﹤0.01% 2055
2021
Q2 		$204K Buy
2,497
+160
+7% +$13.3K ﹤0.01% 1847
2021
Q1 		$223K Buy
+2,337
New +$221K ﹤0.01% 1788

Other funds holding LGND

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
CAM
Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM

Franklin Resources's LGND Position: Q2 2026 in Review

Franklin Resources increased its Ligand Pharmaceuticals (LGND) stake by 31% in Q2 2026, buying an estimated $42.1M and bringing the position to 752,044 shares worth $238M. The position accounts for 0.05% of the portfolio, ranked #296.

Franklin Resources first reported a position in LGND in Q1 2021 and has held it in 19 quarters since. 414 funds tracked by Wall St. Rank hold LGND as of Q2 2026.

  • Franklin Resources held 752,044 shares of Ligand Pharmaceuticals worth $238M as of Q2 2026.
  • Franklin Resources bought 178,867 Ligand Pharmaceuticals shares in Q2 2026, an estimated $42.1M.
  • Ligand Pharmaceuticals made up 0.05% of Franklin Resources's portfolio in Q2 2026, its #296 holding.
  • Franklin Resources first reported a position in Ligand Pharmaceuticals in Q1 2021 and has held it in 19 quarters since.
  • 414 funds tracked by Wall St. Rank held Ligand Pharmaceuticals as of Q2 2026.

Based on Franklin Resources's 13F filing for Q2 2026, filed 13 Aug 2026.